Effective Date:07/01/2016 |
Title:Portrazza (Necitumumab)
|
Revision Date:01/01/2017
|
Document:BI511:00
|
CPT Code(s):J9295
|
Public Statement
|
Effective Date:
a)
This policy
will apply to all services performed on or after the above revision date which
will become the new effective date.
b)
For all
services referred to in this policy that were performed before the revision
date, contact customer service for the rules that would apply.
1)
Portrazza (necitumumab)
requires prior authorization.
2)
Portrazza
is used to treat a type of lung cancer.
3)
Portrazza
is considered a specialty drug and is covered under the medical benefit.
|
Medical Statement
|
Portrazza (necitumumab) is considered medically necessary for patients meeting
all of the following criteria:
1)
Diagnosis
of metastatic squamous non-small cell lung cancer (NSCLC) AND
2)
Is used in
combination with gemcitabine and cisplatin.
Portrazza (necitumumab) is considered experimental and investigational for the
treatment of other solid tumors (not an all-inclusive list):
·
Colorectal
cancer
·
Head and
neck squamous cell carcinoma
·
Non-squamous
NSCLC
|
Limits
|
Intentially left empty
|
Reference
|
1)
Aetna
Medical Clinical Policy Bulletin. Portrazza (necitumumab). Accessed at
http://www.aetna.com/cpb/medical/data/800_899/0898.html
2)
Portrazza
Product Information. Eli Lilly. Indianapolis, IN. November 2015.
3)
Clinical
Pharmacology. Accessed online 03/14/2016.
Addendum:
1)
Effective 1/1/2017:
added J9295 as
appropriate code for Portrazza.
|
Application to Products
|
This policy applies to all health plans and
products administered by QualChoice, both those insured by QualChoice and those
that are self-funded by the sponsoring employer, unless there is indication in
this policy otherwise or a stated exclusion in your medical plan booklet.
Consult the individual plan sponsor Summary Plan Description (SPD) for
self-insured plans or the specific Evidence of Coverage (EOC) or Certificate of
Coverage (COC) for those plans or products insured by QualChoice. In the event
of a discrepancy between this policy and a self-insured customer’s SPD or the
specific QualChoice EOC or COC, the SPD, EOC, or COC, as applicable, will
prevail. State and federal mandates will be followed as they apply.
|
Changes: QualChoice reserves the right to alter, amend, change or supplement benefit interpretations as needed.
|